Tumor mutational load predicts survival after immunotherapy across multiple cancer typesRobert Samstein, Ronald P. DeMatteo, Chung‐Han Lee et al.|Nature Genetics|2019Cited by 4.4k
Immunologic Correlates of the Abscopal Effect in a Patient with MelanomaMichael A. Postow, Jedd D. Wolchok, Matthew Adamow et al.|New England Journal of Medicine|2012Cited by 2.1k
Sebaceous carcinoma: evidence-based clinical practice guidelinesJoshua L. Owen, Michael K. Wong, Nour Kibbi et al.|The Lancet Oncology|2019Cited by 204
Regional Lymph Node Basin (RLNB) Relapse after Adjuvant Ipilimumab (Ipi) Anti-CTLA4 Immunotherapy in Stage III Melanoma: A Subgroup Analysis of a Randomized Placebo-Controlled TrialChristopher A. Barker, Jedd D. Wolchok, K.A. Ahmed et al.|International Journal of Radiation Oncology*Biology*Physics|2017Cited by 1